IRONWOOD PHARMACEUTICALS, INC. Lease Obligation Incurred
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Lease Obligation Incurred of $325.00 thousand for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalLeaseObligationsIncurred · last filed 2011-11-09
- IRONWOOD PHARMACEUTICALS, INC. lease obligation incurred for the quarter ending 2011-09-30 was $0.00, a 100.00% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. lease obligation incurred for the quarter ending 2010-09-30 was $42.00K.
| Period end | Lease Obligation Incurred 3 month | Lease Obligation Incurred 6 month | Lease Obligation Incurred 9 month |
|---|---|---|---|
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $325.00K 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $325.00K 10-Q · filed 2011-08-12 | ||
| 2010-09-30 | $42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $529.00K 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $487.00K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |